Gene · 3925
Papers4,446
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,446
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of stathmin expression in the differential diagnosis, prognosis, and potential treatment of ovarian sex cord-stromal tumors. | Diagn Pathol | 2024 | 39215355 | PubTator, text mining | PubMed |
| Proteomic Profile of Endometrial Cancer: A Scoping Review. | Biology (Basel) | 2024 | 39194522 | PubTator, text mining | PubMed |
| Comprehensive genomic and spatial immune infiltration analysis of survival outliers in extensive-stage small cell lung cancer receiving first-line chemoimmunotherapy. | Int Immunopharmacol | 2024 | 39151386 | PubTator, text mining | PubMed |
| Aberrant telomeric structures and serum markers of telomere dysfunction in healthy aging: a preliminary study. | Biogerontology | 2024 | 39001954 | PubTator, text mining | PubMed |
| Correction to Silencing PCMT1 enhances the sensitivity of breast cancer cells to paclitaxel through the PI3K/Akt/STMN1 pathway. | Chem Biol Drug Des | 2024 | 38982619 | PubTator, text mining | PubMed |
| Restricting Colorectal Cancer Cell Metabolism with Metformin: An Integrated Transcriptomics Study. | Cancers (Basel) | 2024 | 38893174 | PubTator, text mining | PubMed |
| Structure and bioactivity of an insecticidal trans-defensin from assassin bug venom. | Structure | 2024 | 38889720 | PubTator, text mining | PubMed |
| Integrated analysis of ferroptosis and stemness based on single-cell and bulk RNA-sequencing data provide insights into the prognosis and treatment of esophageal carcinoma. | Gene | 2024 | 38885819 | PubTator, text mining | PubMed |
| A novel single-cell model reveals ferroptosis-associated biomarkers for individualized therapy and prognostic prediction in hepatocellular carcinoma. | BMC Biol | 2024 | 38853238 | PubTator, text mining | PubMed |
| Silencing PCMT1 enhances the sensitivity of breast cancer cells to paclitaxel through the PI3K/Akt/STMN1 pathway. | Chem Biol Drug Des | 2024 | 38853025 | PubTator, text mining | PubMed |
| How cytoskeletal crosstalk makes cells move: Bridging cell-free and cell studies. | Biophys Rev (Melville) | 2024 | 38840976 | PubTator, text mining | PubMed |
Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma. | Biomark Res | 2024 | 38840205 | PubTator, text mining | PubMed |
| Effect of 3D and 2D cell culture systems on trophoblast extracellular vesicle physico-chemical characteristics and potency. | Front Cell Dev Biol | 2024 | 38835509 | PubTator, text mining | PubMed |
| Identification of phosphorylated small ORF-encoded peptides in Hep3B cells by LC/MS/MS. | J Proteomics | 2024 | 38823442 | PubTator, text mining | PubMed |
| Transcriptome analysis of porcine oocytes during postovulatory aging. | Theriogenology | 2024 | 38821784 | PubTator, text mining | PubMed |
| [Retracted] Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy. | Oncol Lett | 2024 | 38807666 | PubTator, text mining | PubMed |
| Tubulin Complexity in Cancer and Metastasis. | Adv Exp Med Biol | 2024 | 38805123 | PubTator, text mining | PubMed |
| No Association of Stathmin1 Gene Polymorphism with Trait or State Anxiety in the Chinese Population. | Alpha Psychiatry | 2024 | 38799486 | PubTator, text mining | PubMed |
| Paris saponin VII inhibits triple-negative breast cancer by targeting the MEK/ERK/STMN1 signaling axis. | Phytomedicine | 2024 | 38763012 | PubTator, text mining | PubMed |
| GTSE1 promotes nasopharyngeal carcinoma proliferation and angiogenesis by upregulating STMN1. | Cell Div | 2024 | 38698443 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3925/papers?page=9